Fibrinogen Deficiency with Thrombotic Manifestations

  • Alvaro Tamayo-Velasco Hospital Clínico Universitario de Valladolid
  • María José Cebeira Haematology and Haemotherapy Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
  • Carolina Bombín-Canal Haematology and Haemotherapy Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain
  • Rosa María Acevedo-García Haematology and Haemotherapy Department, Complejo Hospitalario Insular Materno Infantil de Gran Canaria, Las Palmas de Gran Canaria, Las Palmas, Spain
  • María Jesús Peñarrubia-Ponce Haematology and Haemotherapy Department, Hospital Clínico Universitario de Valladolid, Valladolid, Spain


Fibrinogen deficiency, thrombosis, thrombophilia, congenital hypodysfibrinogenemia, ROTEM


Fibrinogen deficiencies are very rare. Qualitative fibrinogen deficiencies (dysfibrinogenaemia and hypodysfibrinogenemia) are functional disorders that can present with both haemorrhagic symptoms and with thrombotic phenomena as unique and paradoxical manifestation. We present the case of a 77-year-old man being investigated for a partially thrombosed abdominal aortic aneurysm as well as an ischaemic stroke 20 years previously. Basic coagulation tests were normal but extended tests revealed a lengthened thrombin time (TT) combined with a significant drop in fibrinogen concentration measured with the Clauss assay and by nephelometry. After secondary fibrinogen deficiencies were ruled out, a heterozygous variant in the FGG gene was detected by next-generation sequencing, and congenital hypodysfibrinogenemia was diagnosed. Acenocumarol was initiated and no new thrombotic or haemorrhagic events had occurred after a year of follow-up.
In almost 25% of cases, thrombotic events may be the only clinical manifestation of functional fibrinogen deficiencies. They are a rare cause of thrombophilia, and are probably underdiagnosed due to normal standard coagulation test results as well as a possible absence of haemorrhagic events. Consequently, a TT test (an initial ‘rule out’ test) should be requested in order to promptly identify these patients. Moreover, discrepancies in derived and Clauss fibrinogen test results should suggest a functional disorder. Finally, new coagulation techniques based on the functional characterization of clot formation, such as ROTEM or thrombin generation assay, could help characterize these entities and suggest new therapeutic approaches.



  • Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 2014 Nov;167(3):304–326.
  • Casini A, Neerman-Arbez M, Ariëns RA, de Moerloose P. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. J Thromb Haemost 2015 Jun;13(6):909–919.
  • Santacroce R, Cappucci F, Pisanelli D, Perricone F, Papa ML, Santoro R, et al. Inherited abnormalities of fibrinogen: 10-year clinical experience of an Italian group. Blood Coagul Fibrinolysis 2006 Jun;17(4):235–240.
  • Acharya SS, Dimichele DM. Rare inherited disorders of fibrinogen. Haemophilia 2008 Nov;14(6):1151–1158.
  • Szanto T, Lassila R, Lemponen M, Lehtinen E, Neerman-Arbez M, Casini A. Whole blood thromboelastometry by ROTEM and thrombin generation by Genesia according to the genotype and clinical phenotype in congenital fibrinogen disorders. Int J Mol Sci 2021 Feb 25;22(5):2286.
  • Published: 2022-06-28

    Issue: 2022: Vol 9 No 6 (view)

    Section: Articles

    How to cite:
    Tamayo-Velasco A, Cebeira MJ, Bombín-Canal C, Acevedo-García RM, Peñarrubia-Ponce MJ. Fibrinogen Deficiency with Thrombotic Manifestations. EJCRIM 2022;9 doi:10.12890/2022_003400.